Niki BioSolutions, Inc.
NIKI • Biotechnology
Strong market move
NIKI-14.84%
vs. previous close $9.70
$8.26
▼ -1.44 (-14.84%)
Current price
EarningsLatest report: Dec 31, 2025
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$60.73M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.15Weak liquidity · 0.78Negative growth trendWeak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Apr 28, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$8.26
Change-14.84%
Shares Out7.35M
Market Cap$60.73M
Enterprise Value$60.80M
Beta0.00
P/E-10.78
P/B2.63
P/FCF-6.77
EV/EBITDA-12.20
EV/FCF-6.78
Earnings Yield-9.27%
Price$8.26
Change-14.84%
Shares Out7.35M
Market Cap$60.73M
Enterprise Value$60.80M
Beta0.00
P/E-10.78
P/B2.63
P/FCF-6.77
EV/EBITDA-12.20
EV/FCF-6.78
Earnings Yield-9.27%
FCF Yield-14.78%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.15
Current Ratio0.78
Quick Ratio0.78
Volume202.99K
Avg Volume0.00
EPS Surprise3.21
Investment DNA
How strong this company looks for long-term investors
38
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
44/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.15Weak liquidity · 0.78Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 2 analyst votes · 2026-09-05
100/100
Bullish
Bullish
2
Hold
0
Bearish
0
🧾
No insider activity
No recent insider transactions available.